Tempus AI Inc. has announced its involvement in nearly 1,500 research projects over the past decade, marking a significant milestone in its mission to advance precision medicine and improve patient care. Utilizing its AI-powered platform, Tempus has collaborated with top academic institutions, community health systems, and biopharma organizations to propel cutting-edge research. Notably, Tempus has contributed to approximately 1,000 biopharma research projects and nearly 500 provider-led initiatives. Their diagnostic assays have yielded clinically-relevant insights across more than 200 projects. Additionally, Tempus' biological modeling lab has supported around 65 research initiatives, enhancing understanding in therapy selection and drug discovery. These efforts align with Tempus' commitment to delivering data-driven insights that improve patient outcomes and accelerate scientific discovery.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.